The effects of lipophilic antioxidants on the affinity of LDL to its receptor: A model for prevention of atherogenesis

Iranian Biomedical Journal

Volumn 6, Issue 4, 2002, Pages 111-115

  Safari, Mohammad Reza ^a   Taherkhani, Heshmatollah ^a   Ani, Mohsen ^b   Naderi, Gholam Ali ^b   Asgary, Sedige ^b  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

LDL; LDL receptor; Vitamin E; Volatile oil

Indexed keywords

ALPHA TOCOPHEROL; ANETHOLE; ANTIOXIDANT; ESSENTIAL OIL; EUGENOL; GERANIOL; LIMONENE; LINALOOL; LOW DENSITY LIPOPROTEIN RECEPTOR; PULEGONE; THYMOL;

ADRENAL GLAND; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BINDING AFFINITY; CATTLE; CONCENTRATION RESPONSE; DRUG EFFECT; FEMALE; FLUORESCENCE; INCUBATION TIME; MALE; MODEL; NONHUMAN; PLASMA; PROTEIN ISOLATION; RECEPTOR AFFINITY; RECEPTOR BINDING; SUPERNATANT; TEMPERATURE; ULTRACENTRIFUGATION;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0036824314     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Feilding, J. and Christopher, J. (1992) Lipoprotein receptors, plasma cholesterol metabolism and the regulation of cellular free cholesterol concentration. FASEB. J 6: 3162-3168.
2. Brown, M.S., Kovanen, P.T. and Goldstein, J.L. (1984) How LDL receptor influences cholesterol and atherosclerosis. Sci. Am. 251: 58-65.
3. Patel, D., Forder, R., Souter, A.K. and Knight, B. (1997) Synthesis and properties of the VLDL receptor and a comparison with the LDL receptor. Biochemistry 324: 371-377.
4. Saxena, K. and Shipley, G.G. (1997) Structural studies of detergent solubilized and vesicle reconstituted LDL receptor. Biochemistry. 36: 15940-15948.
5. Ross, R. (1994) Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340: 115-126.
6. Krauss, R.M. (1994) Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr. Opin. Lipidol. 5: 339-349.
7. Hannah, J.S., Yamane, K., Kataoka, S., Anthony, M. and Howard, B.V. (1997) High fat, high cholesterol diets alter low-density lipoprotein size and binding affinity in monkeys. Atherosclerosis 132: 19-27.
8. Leake, D.S. (1993) Oxidized low-density lipoproteins and atherogenesis. Br. Heart J. 69: 476-478.
9. Witztum, J.L., Mahoney, E.M., Branks, M.J., Fisher, M. and Steinberg, D. (1982) Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes 31: 283-290.
10. Traber, M.G. and Kayden, H.J. (1984) Vitamin E is delivered to cells via the high affinity receptor for low-density lipoprotein. Am. J. Clin. Nutr. 40 (4): 747-751.
11. Wagner, B., Buettner, G.R. and Patrick-Burns, C. (1996) Vitamin E slows the rate of free radical-mediated lipid peroxidation in cells. Arch. Biochem. Biophys. 334 (2): 261-267.
12. Nardini, M., Natella, F., Gentili, V. and Di-Felice, M. (1997) Effect of caffeic acid dietary supplementation on the antioxidant defense system in rat: an in vivo study. Arch. Biochem. Biophys. 342 (1): 157-160.
13. Fremant, L., Belguendouz, L. and Delpal, S. (1999), Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci. 64 (26): 2511-2521.
14. Naidu, K.A. and Thippeswamy, N.B. (2002) Inhibition of human density lipoprotein oxidation by active principles from spices. Mol. Cell Biochem. 229 (1-2). 19-23.
15. Rajalakshmi, K., Gurumurthi, P. and Devaraj, S.N. (2000) Effect of eugenol and tincture of crataegus (TCR) on in vitro oxidation of LDL + VLDL isolated from plasma of non-insulin dependent diabetic patients. Indian J. Biol. 38 (5): 509-511.
16. Murakami, M., Horiuchi, S., Takata, K. and Morino, Y. (1987) Distinction in the mode of receptor-mediated endocytosis between high-density lipoprotein and acetylated high-density lipoprotein: evidence for high-density lipoprotein receptor-mediated cholesterol transfer. J. Biochem. (Tokyo) 1729-1741.
17. Schneider, W.J., Goldstein, J.L. and Brown, M.S. (1982) Purification of the LDL receptor. Meth. Enzymol. 109: 405-417.
18. Feurstein, D.L. and Sellek, R.E. (1965) The chemical stability of fluoresein under normal fluorometric condition. J. Sanit. Eng. Div. Am. Soc. 89: 1-11.
19. Kontush, A., Hubner, C., Finckh, B., Kohlschutter, A. and Beisiegel, U. (1995) Antioxidative activity of ubiquinol-10 at physiologic concentrations in human low-density lipoprotein. Biochem. Biophys. Acta. 1258: 177-187.
20. Goldstein, J.L. and Brown, M.S. (1974) Binding and degradation of low-density lipoproteins by cultured human fibroblasts. J. Biol. Chem. 249: 5153-5162.
21. Shen, M.S., Krauss, R.M., Lindgren, F.T. and Forte, T.M. (1981) Heterogeneity of serum low density lipoproteins in normal human subjects. J. Lipid Res. 22: 236-244.
22. Nelson, C.A. and Morris, M.D. (1977) The ultracentrifugal heterogeneity of serum low-density lipoproteins in normal humans. Biochem. Med 18: 1-8.
23. Kirchhausen, T.G., Fless, G. and Scanu, A.M. (1980) The structure of plasma low density lipoproteins: experimental facts and interpretation-a minireview. Lipids 15: 464-467.
24. Sundaram, S.G., Shakir, K.M.M. and Margolis, S. (1978) Preparative isoelectric focusing of human serum very low density and low-density lipoproteins. Anal. Biochem. 88: 425-433.
25. Rudel, L.L., Parks, J.S., Johnson, F.L. and Babiak, J. (1986) Low-density lipoproteins in atherosclerosis. J. Lipid Res. 27: 465-474.
26. Cohn, W. and Kuhn, H. (1989) The role of the low-density lipoprotein receptor for alpha-tocopherol delivery to tissues. Ann. N.Y. Acad Sci. 570: 61-71.
27. Sakuma, N., Yosikawa, M., Hibino, T., Okada, M., Jinno, Y., Tamai, N. and Ohshima, K. (1998) Alpha-tocopherol protects the peroxidative modification of LDL to be recognized by LDL receptors. J. Nutr. Sci. Vitaminol (Tokyo) 44 (5): 697-703.
28. Giugliano, D. (2000) Dietary antioxidants for cardiovascular prevention. Nutr. Metab. Cardiovasc. Dis. 10 (1): 38-44.
29. Leonhardt, W., Hanefeld, M. and Schaper, F. (1999) Diminished susceptibility to in vitro oxidation of low-density lipoproteins in hypercholesterolemia: key role of α-tocopherol content. Atherosclerosis 144: 103-107.
30. Bowry, V.W., Ingold, K.V. and Stocker, R. (1992) Vitamin E in human LDL: when and how this antioxidant becomes a prooxidant. Biochem. J. 288: 341-344.
31. Crawford, R.S., Kirk, E.A., Rosenfeld, M.E., LeBoeuf, R.C. and Chait, A. (1998) Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18(9): 1506-1513.
32. Teissedre, P.L. and Waterhouse, A.L. (2000) Inhibition of oxidation of human low-density lipoproteins by phenolic substances in different essential oils varieties. J. Agric. Food Chem. 48 (9): 3801-3805.
33. Grassmann, J., Schneider, D., Weiser, D. and Elstner, E.F. (2001) Antioxidative effects of lemon oil and its components on copper induced oxidation of low-density lipoprotein. Arzneimittelforschung 51 (10): 799-805.
34. Wilcox, L.J., Borradaile, N.M., Dreu, L.E. and Huff, M.W. (2001) Secretion of hepatocyte apoB is inhibited by the flavonoids and essential oils, via reduced activity and expression of ACAT2 and MTP. J. Lipid Res. 42 (5): 725-734.